Thu, Jul 24, 2014, 7:10 PM EDT - U.S. Markets closed

Recent

% | $
Click the to save as a favorite.

DARA BioSciences, Inc Message Board

  • petecook68 petecook68 Jul 31, 2013 9:12 PM Flag

    Why Dara is a Good Long!

    The only statistic anyone needs to be able to comprehend is the FACT that treatment for CCIPN is estimated at 5 BILLION DOLLARS A YEAR BY 2015!

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • a twist on words petey? this would be like me saying it will be a FACT if i win the lottery that I"LL BE RICH! now what happens if dara runs out of funds between now and then to get it in gear.before answering keep in mind they are only two years behind so far with nothing else to bring in the dough to pay bills.can you say dilution. lol keep pumping and i'll correct you every time. lol

      • 1 Reply to mitchandpeteareidiots
      • Wake up loser! All I have ever stated and believed in is that a partnership is inevitable and when that does does occur here shortly, there will be no need for dilution. Final verdict on odd decides who the partner is. Knowing there are no known therapies for ccipn, and take a minimal market penetration of 1% of the 5 billion estimate for treatment, then krn5500 and daras revenue is $50,000,000.00 a year That has nothing to do with the other revenue from the other oncology supportive products increasing output. The only twist on words that exists is the FACT that you will be the one on the lawn chair and on the train tracks! RIP!!! (LOL)

    • Eye am slowly accumulating in here......started at .72 then added at .57 and now in mid .60's......this is a great long termer and eye am the king of patience who outlasts all...................

 
DARA
1.41-0.08(-5.37%)Jul 24 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.